Universal Biopharmaresearch is categorized under Commercial Physical Research in Dinuba, CA and active since 2000.
Universal Biopharmaresearch was established in 2000, and today employs 1 to 4, earning Unknown per year. This is a Commercial Physical Research business, which does work in the B2B market, and is classified as a Commercial Physical Research, under code number 5417114 by the NAICS.
If you are seeking more information, feel free to contact Kuldip Thusu, Chief Executive Officer at the company’s single location by writing to 888 North Alta Avenue, Dinuba, California CA 93618 or by phoning (559) 595-1861. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Universal Biopharmaresearch |
Contact Person: | Kuldip Thusu, Chief Executive Officer |
Address: | 888 North Alta Avenue, Dinuba, California 93618 |
Phone Number: | (559) 595-1861 |
Annual Revenue (USD): | Unknown |
Founded: | 2000 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Physical Research |
SIC Code: | 8731 |
NAICS Code: | 5417114 |
Share This Business: |
Universal Biopharmaresearch was started in 2000 to provide professional Commercial Physical Research under the SIC code 8731 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Kuldip Thusu, Chief Executive Officer for inquiries that concern Universal Biopharmaresearch by calling the company number (559) 595-1861, as your correspondence is most welcome. Additionally, the physical location of the single location of Universal Biopharmaresearch can be found at the coordinates 36.55287,-119.39496 as well as the street address 888 North Alta Avenue in Dinuba, California 93618.
For its online presence, you may visit Universal Biopharmaresearch’s website at and engage with its social media outlets through on Twitter and on Facebook.